Annual Long Term Debt
$1.64 M
-$761.00 K-31.67%
December 31, 2023
Summary
- As of February 7, 2025, AVIR annual long term debt is $1.64 million, with the most recent change of -$761.00 thousand (-31.67%) on December 31, 2023.
- AVIR annual long term debt is now -31.67% below its all-time high of $2.40 million, reached on December 31, 2022.
Performance
AVIR Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$1.04 M
-$200.00 K-16.06%
September 30, 2024
Summary
- As of February 7, 2025, AVIR quarterly long term debt is $1.04 million, with the most recent change of -$200.00 thousand (-16.06%) on September 30, 2024.
- Over the past year, AVIR quarterly long term debt has dropped by -$790.00 thousand (-43.05%).
- AVIR quarterly long term debt is now -62.22% below its all-time high of $2.77 million, reached on June 30, 2022.
Performance
AVIR Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
AVIR Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.7% | -43.0% |
| 3 y3 years | - | -43.0% |
| 5 y5 years | - | -43.0% |
AVIR Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -31.7% | -100.0% | -62.2% | -100.0% |
| 5 y | 5-year | -31.7% | -100.0% | -62.2% | -100.0% |
| alltime | all time | -31.7% | -100.0% | -62.2% | -100.0% |
Atea Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.04 M(-16.1%) |
| Jun 2024 | - | $1.25 M(-13.8%) |
| Mar 2024 | - | $1.45 M(-12.0%) |
| Dec 2023 | $1.64 M | $1.64 M(-10.5%) |
| Sep 2023 | - | $1.83 M(-9.4%) |
| Jun 2023 | - | $2.03 M(-8.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $2.21 M(-7.8%) |
| Dec 2022 | $2.40 M(>+9900.0%) | $2.40 M(-7.0%) |
| Sep 2022 | - | $2.58 M(-6.5%) |
| Jun 2022 | - | $2.77 M(+0.1%) |
| Mar 2022 | - | $2.76 M(>+9900.0%) |
| Dec 2021 | $0.00 | $0.00 |
FAQ
- What is Atea Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals annual long term debt year-on-year change?
- What is Atea Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Atea Pharmaceuticals?
- What is Atea Pharmaceuticals quarterly long term debt year-on-year change?
What is Atea Pharmaceuticals annual long term debt?
The current annual long term debt of AVIR is $1.64 M
What is the all time high annual long term debt for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high annual long term debt is $2.40 M
What is Atea Pharmaceuticals annual long term debt year-on-year change?
Over the past year, AVIR annual long term debt has changed by -$761.00 K (-31.67%)
What is Atea Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of AVIR is $1.04 M
What is the all time high quarterly long term debt for Atea Pharmaceuticals?
Atea Pharmaceuticals all-time high quarterly long term debt is $2.77 M
What is Atea Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, AVIR quarterly long term debt has changed by -$790.00 K (-43.05%)